Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates
- PMID: 20547802
- PMCID: PMC2935005
- DOI: 10.1128/AAC.00330-10
Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates
Similar articles
-
In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.Antimicrob Agents Chemother. 2012 Aug;56(8):4500-3. doi: 10.1128/AAC.00045-12. Epub 2012 May 21. Antimicrob Agents Chemother. 2012. PMID: 22615296 Free PMC article.
-
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.Antimicrob Agents Chemother. 2008 Aug;52(8):2919-22. doi: 10.1128/AAC.00323-08. Epub 2008 May 5. Antimicrob Agents Chemother. 2008. PMID: 18458136 Free PMC article.
-
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Antimicrob Agents Chemother. 2011 May;55(5):1968-74. doi: 10.1128/AAC.00959-10. Epub 2011 Feb 22. Antimicrob Agents Chemother. 2011. PMID: 21343465 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Anidulafungin: when and how? The clinician's view.Mycoses. 2012 Jan;55(1):36-44. doi: 10.1111/j.1439-0507.2011.02052.x. Epub 2011 Jun 13. Mycoses. 2012. PMID: 21668526 Review.
Cited by
-
Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint.Antimicrob Agents Chemother. 2015 Mar;59(3):1759-66. doi: 10.1128/AAC.04545-14. Epub 2014 Dec 15. Antimicrob Agents Chemother. 2015. PMID: 25512402 Free PMC article.
-
Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles.J Clin Microbiol. 2012 Aug;50(8):2748-54. doi: 10.1128/JCM.00610-12. Epub 2012 Jun 12. J Clin Microbiol. 2012. PMID: 22692739 Free PMC article.
References
-
- Chandrasekar, P. H., and E. Manavathu. 2001. Voriconazole, a second generation triazole. Drugs Today 37:135-148. - PubMed
-
- Clinical and Laboratory Standards Institute. 2008. M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeasts: third edition. Clinical and Laboratory Standards Institute, Wayne, PA.
-
- Clinical and Laboratory Standards Institute. 2008. M27-S3. Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
-
- Diekema, D. J., S. A. Messer, R. J. Hollis, L. Boyken, S. Tendolkar, J. Kroeger, R. N. Jones, and M. A. Pfaller. 2009. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diagn. Microbiol. Infect. Dis. 63:233-236. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources